S. 2529: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014

113th Congress · introduced 2014-06-25 · Health · Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

federal

Follow this bill, step by step

Where it came from: introduced 2014-06-25 · official record
Who proposed it: Sen. Shaheen, Jeanne [D-NH] · what a sponsor is
What happened next: no floor votes in our records yet. Why?
Where it stands now: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Not final yet: this can still change. We check for updates every day.
If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014

Plain summary

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists. Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to: allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require submission by a state of a plan to apply the latest advances in health information technology to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers, require timelines and descriptions for implementation of interoperability for purposes of information sharing with a bordering state that already operates a monitoring program, require health information interoperability standards to be consistent with at least one health information technology system, require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and expand the program to include any commonwealth or territory of the United States. Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes. Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society. Removes the preferences for grants related to drug abuse for states with approved applications to implement controlled substances monitoring programs. Revises requirements for studies on progress to include assessment of the effects upon linkages to substance abuse disorder services and interoperability with health information technology systems.

Congressional Research Service summary (Introduced in Senate), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014

Source: Congressional Research Service summary (Introduced in Senate)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Sen. Shaheen, Jeanne [D-NH] · 11 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Richard J. Durbin (D-IL), Charles E. Schumer (D-NY), Kirsten E. Gillibrand (D-NY), Elizabeth Warren (D-MA), Edward J. Markey (D-MA)

Sponsor's campaign money: Sen. Shaheen, Jeanne [D-NH] reported raising $176,810 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)

Appropriation: Money a legislature sets aside by law for a specific purpose. Government agencies may spend public money only as it has been appropriated.

Plain meanings written from linked sources. All words.

Sources

Congressional Research Service summary (Introduced in Senate)
Congress.gov
Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-113s2529.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/113/s>

Record fed-us-cong113-s2529 · catalog fed-us-congress-bills-cong113 · updated 2026-11-15 by psicol fed-bills-cong113